AU2021230341C8 - Compositions and methods for detecting SARS-CoV-2 nucleic acid - Google Patents

Compositions and methods for detecting SARS-CoV-2 nucleic acid

Info

Publication number
AU2021230341C8
AU2021230341C8 AU2021230341A AU2021230341A AU2021230341C8 AU 2021230341 C8 AU2021230341 C8 AU 2021230341C8 AU 2021230341 A AU2021230341 A AU 2021230341A AU 2021230341 A AU2021230341 A AU 2021230341A AU 2021230341 C8 AU2021230341 C8 AU 2021230341C8
Authority
AU
Australia
Prior art keywords
seq
cov
sars
target
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021230341A
Other languages
English (en)
Other versions
AU2021230341B2 (en
AU2021230341C1 (en
AU2021230341A1 (en
Inventor
Paul M. Darby
Barbara Lynn EATON
Damon Kittredge Getman
Joshua Kalani MOBERLY
Jimmykim PHAM
Ankur H. Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of AU2021230341A1 publication Critical patent/AU2021230341A1/en
Publication of AU2021230341B2 publication Critical patent/AU2021230341B2/en
Priority to AU2025283673A priority Critical patent/AU2025283673A1/en
Application granted granted Critical
Publication of AU2021230341C1 publication Critical patent/AU2021230341C1/en
Publication of AU2021230341C8 publication Critical patent/AU2021230341C8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2021230341A 2020-03-04 2021-03-04 Compositions and methods for detecting SARS-CoV-2 nucleic acid Active AU2021230341C8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025283673A AU2025283673A1 (en) 2020-03-04 2025-12-22 Compositions and methods for detecting SARS-CoV-2 nucleic acid

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202062985139P 2020-03-04 2020-03-04
US62/985,139 2020-03-04
US202063010186P 2020-04-15 2020-04-15
US63/010,186 2020-04-15
US202063020007P 2020-05-04 2020-05-04
US63/020,007 2020-05-04
US202063078790P 2020-09-15 2020-09-15
US63/078,790 2020-09-15
PCT/US2021/020839 WO2021178644A1 (en) 2020-03-04 2021-03-04 Compositions and methods for detecting sars-cov-2 nucleic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025283673A Division AU2025283673A1 (en) 2020-03-04 2025-12-22 Compositions and methods for detecting SARS-CoV-2 nucleic acid

Publications (4)

Publication Number Publication Date
AU2021230341A1 AU2021230341A1 (en) 2022-10-27
AU2021230341B2 AU2021230341B2 (en) 2025-11-20
AU2021230341C1 AU2021230341C1 (en) 2026-03-26
AU2021230341C8 true AU2021230341C8 (en) 2026-05-07

Family

ID=75396848

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2021230341A Active AU2021230341C8 (en) 2020-03-04 2021-03-04 Compositions and methods for detecting SARS-CoV-2 nucleic acid
AU2025283673A Pending AU2025283673A1 (en) 2020-03-04 2025-12-22 Compositions and methods for detecting SARS-CoV-2 nucleic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025283673A Pending AU2025283673A1 (en) 2020-03-04 2025-12-22 Compositions and methods for detecting SARS-CoV-2 nucleic acid

Country Status (6)

Country Link
US (1) US20230117369A1 (cg-RX-API-DMAC7.html)
EP (2) EP4582563A3 (cg-RX-API-DMAC7.html)
JP (2) JP2023516683A (cg-RX-API-DMAC7.html)
AU (2) AU2021230341C8 (cg-RX-API-DMAC7.html)
CA (1) CA3174532A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021178644A1 (cg-RX-API-DMAC7.html)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422956A1 (fr) 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
JP2641880B2 (ja) 1986-08-11 1997-08-20 シスカ・ダイアグノスティックス・インコーポレーテッド 核酸プローブアッセイ法および組成物
US5541308A (en) 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
WO1989002476A1 (en) 1987-09-21 1989-03-23 Ml Technology Ventures, L.P. Homogeneous protection assay
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5656207A (en) 1989-06-24 1997-08-12 Gen Probe Incorporated Detecting or quantifying multiple analytes using labelling techniques
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
WO1993022461A1 (en) 1992-05-06 1993-11-11 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
CA2141430C (en) 1992-08-04 2009-05-12 Sherrol H. Mcdonough Nucleic acid sequence amplification
JP3026843B2 (ja) 1993-07-23 2000-03-27 ジェン−プローブ・インコーポレーテッド 核酸増幅の促進法
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
EP0709466B1 (en) 1994-10-28 2006-09-27 Gen-Probe Incorporated Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
US5731148A (en) 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
AU713667B2 (en) 1996-04-12 1999-12-09 Phri Properties, Inc. Detection probes, kits and assays
DK0975807T3 (da) 1997-05-02 2007-01-29 Gen Probe Inc To-trins hybridisering og indfangning af et polynukleotid
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
EP1092047B1 (en) 1998-07-02 2009-08-26 Gen-Probe Incorporated Molecular torches
JP5020818B2 (ja) 2004-07-01 2012-09-05 ジェン−プローブ・インコーポレーテッド 生物学的試料中の核酸を検出するための方法及び組成物
CA2898814C (en) 2004-08-27 2015-12-29 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
AU2006218794A1 (en) 2005-02-28 2006-09-08 Gen-Probe Incorporated Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe
WO2008016988A1 (en) 2006-08-01 2008-02-07 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
DK2890814T3 (da) 2012-08-30 2019-12-16 Gen Probe Inc Flerfaset nukleinsyreamplificering

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Corman VM et al, "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", Eurosurveillance, 23 January 2020, 25(3):2000045, doi: 10.2807/1560-7917.ES.2020.25.3.2000045 *
WHO TEAM: "Molecular assays to diagnose COVID-19: Summary table of available protocols", 24 January 2020 (2020-01-24), *
YINHUA ZHANG ET AL: "Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP", MEDRXIV, 29 February 2020, 2020-02, doi: 10.1101/2020.02.26.20028373 *

Also Published As

Publication number Publication date
AU2025283673A1 (en) 2026-01-22
EP4114985C0 (en) 2025-05-07
JP2026022657A (ja) 2026-02-12
US20230117369A1 (en) 2023-04-20
CA3174532A1 (en) 2021-09-10
JP2023516683A (ja) 2023-04-20
EP4582563A2 (en) 2025-07-09
EP4114985A1 (en) 2023-01-11
EP4582563A3 (en) 2025-10-08
EP4114985B1 (en) 2025-05-07
AU2021230341B2 (en) 2025-11-20
AU2021230341C1 (en) 2026-03-26
WO2021178644A1 (en) 2021-09-10
AU2021230341A1 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
US20240240270A1 (en) Compositions and methods for detection of viral pathogens in samples
AU2014306512C1 (en) Compositions and methods for detecting HEV nucleic acid
AU2021230341C1 (en) Compositions and methods for detecting SARS-CoV-2 nucleic acid
WO2024050540A2 (en) Compositions and methods for detection of viral pathogens in samples
AU2019314449B2 (en) Compositions and methods for detecting nucleic acids of Epstein-Barr virus
HK40087028B (en) Compositions and methods for detecting sars-cov-2 nucleic acid
HK40087028A (en) Compositions and methods for detecting sars-cov-2 nucleic acid
US20230399708A1 (en) Compositions and Methods for Detecting Influenza A, Influenza B, and SARS-CoV-2
US20230082096A1 (en) Compositions and methods for detecting coronavirus nucleic acid
EP4337797A1 (en) Compositions and methods for detecting human adenovirus nucleic acid

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20 NOV 2025

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED

FGA Letters patent sealed or granted (standard patent)
TH Corrigenda

Free format text: IN VOL 60 , NO 12 , PAGE(S) 1925 UNDER THE HEADING AMENDMENTS - AMENDMENTS MADE PLEASE NOTE THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED SHOULD READ 20 NOV 2025